Description
REPORTING OF FUNDS FOR FY2009
First action · last action
2009-04-16 · 2009-04-16
Transactions
1
First transaction's obligation
$25,500
Base + all options value (sum of deltas)
$0
Extent competed
—
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
0
SDVOSB flag on record
No
Parent IDV
VA261BP0046
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2009-04-16+$25,500= $25,500
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2009-04-16 | +$25,500 | $25,500 | REPORTING OF FUNDS FOR FY2009 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI P31QQPK7RDA5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26026N0385 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $167,781 | FY2026 |
| 36C24426P0411 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $56,685 | FY2026 |
| 36C25026N0494 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $71,078 | FY2026 |
| 36C25926N0302 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $48,920 | FY2026 |
| 36C24426P0173 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $27,580 | FY2026 |
| 36C26026A0009 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
Other recipients under J065 from 261-NETWORK CONTRACT OFFICE 21 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26116P1358 | BOSTON SCIENTIFIC CORP | 261-NETWORK CONTRACT OFFICE 21 | $8,716 | FY2016 |
| VA26116F0877 | OLYMPUS AMERICA INC | 261-NETWORK CONTRACT OFFICE 21 | $15,476 | FY2016 |
| VA26116P1118 | ETHICON, INC | 261-NETWORK CONTRACT OFFICE 21 | $13,095 | FY2016 |
| VA26116P0940 | CARESTREAM HEALTH, INC | 261-NETWORK CONTRACT OFFICE 21 | $6,988 | FY2016 |
| VA26116P0906 | GENERAL ELECTRIC COMPANY | 261-NETWORK CONTRACT OFFICE 21 | $11,416 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA0002_3600_VA261BP0046_3600 · retrieved 2026-09-26.